252 related articles for article (PubMed ID: 7971256)
1. Homozygous or compound heterozygous qualitative antithrombin III deficiency.
Cucuianu M; Blaga S; Pop S; Olinic D; Olinic N; Colhon D; Cristea A
Nouv Rev Fr Hematol (1978); 1994 Aug; 36(4):335-7. PubMed ID: 7971256
[TBL] [Abstract][Full Text] [Related]
2. Antithrombin III deficiency.
Cucuianu M; Blaga S; Pop S; Olinic D; Olinic N; Colhon D; Cristea A
Rom J Intern Med; 1994; 32(2):119-27. PubMed ID: 7920326
[TBL] [Abstract][Full Text] [Related]
3. Homozygous variant of antithrombin III: AT III Fontainebleau.
Boyer C; Wolf M; Vedrenne J; Meyer D; Larrieu MJ
Thromb Haemost; 1986 Aug; 56(1):18-22. PubMed ID: 3775688
[TBL] [Abstract][Full Text] [Related]
4. Homozygous variant of antithrombin III that lacks affinity for heparin, AT III Kumamoto.
Okajima K; Ueyama H; Hashimoto Y; Sasaki Y; Matsumoto K; Okabe H; Inoue M; Araki S; Takatsuki K
Thromb Haemost; 1989 Feb; 61(1):20-4. PubMed ID: 2749590
[TBL] [Abstract][Full Text] [Related]
5. Antithrombin III Alger: a new homozygous AT III variant.
Fischer AM; Cornu P; Sternberg C; Mériane F; Dautzenberg MD; Chafa O; Beguin S; Desnos M
Thromb Haemost; 1986 Apr; 55(2):218-21. PubMed ID: 3715788
[TBL] [Abstract][Full Text] [Related]
6. Report of a novel kindred with antithrombin heparin-binding site variant (47 Arg to His): demand for an automated progressive antithrombin assay to detect molecular variants with low thrombotic risk.
Rossi E; Chiusolo P; Za T; Marietti S; Ciminello A; Leone G; De Stefano V
Thromb Haemost; 2007 Sep; 98(3):695-7. PubMed ID: 17849067
[No Abstract] [Full Text] [Related]
7. Familial variant of antithrombin III (AT III Bligny, 47Arg to His) associated with protein C deficiency.
Wolf M; Boyer-Neumann C; Molho-Sabatier P; Neumann C; Meyer D; Larrieu MJ
Thromb Haemost; 1990 Apr; 63(2):215-9. PubMed ID: 2363123
[TBL] [Abstract][Full Text] [Related]
8. Antithrombin III Geneva: a hereditary abnormal AT III with defective heparin cofactor activity.
de Moerloose PA; Reber G; Vernet P; Minazio P; Bouvier CA
Thromb Haemost; 1987 Apr; 57(2):154-7. PubMed ID: 3603409
[TBL] [Abstract][Full Text] [Related]
9. [Antithrombin deficiency due to heterozygous antithrombin gene mutation and a pedigree study].
Ye X; Feng Y; Jin PP; Zhou XH; Ding QL; Wang XF
Zhonghua Xue Ye Xue Za Zhi; 2007 Sep; 28(9):587-9. PubMed ID: 18246812
[TBL] [Abstract][Full Text] [Related]
10. Antithrombin III "Northwick Park": a variant antithrombin with normal affinity for heparin but reduced heparin cofactor activity.
Howarth DJ; Samson D; Stirling Y; Seghatchian MJ
Thromb Haemost; 1985 Jun; 53(3):314-9. PubMed ID: 4049307
[TBL] [Abstract][Full Text] [Related]
11. An antithrombin III assay based on factor Xa inhibition provides a more reliable test to identify congenital antithrombin III deficiency than an assay based on thrombin inhibition.
Demers C; Henderson P; Blajchman MA; Wells MJ; Mitchell L; Johnston M; Ofosu FA; Fernandez-Rachubinski F; Andrew M; Hirsh J
Thromb Haemost; 1993 Mar; 69(3):231-5. PubMed ID: 8470046
[TBL] [Abstract][Full Text] [Related]
12. [Abnormal antithrombin III: abnormalities of heparin or protease binding domain].
Sakuragawa N; Niiya K; Takahashi K; Hayashi T; Oguma Y; Saitoh S
Rinsho Byori; 1993 May; 41(5):492-505. PubMed ID: 8350512
[TBL] [Abstract][Full Text] [Related]
13. Characterization of an abnormal antithrombin (Milano 2) with defective thrombin binding.
Tripodi A; Krachmalnicoff A; Mannucci PM
Thromb Haemost; 1986 Dec; 56(3):349-52. PubMed ID: 3563966
[TBL] [Abstract][Full Text] [Related]
14. Hereditary homozygous heparin cofactor II deficiency and the risk of developing venous thrombosis.
Villa P; Aznar J; Vaya A; España F; Ferrando F; Mira Y; Estellés A
Thromb Haemost; 1999 Sep; 82(3):1011-4. PubMed ID: 10494755
[TBL] [Abstract][Full Text] [Related]
15. Inherited antithrombin III deficiency and cerebral thrombosis in a child.
Ambruso DR; Jacobson LJ; Hathaway WE
Pediatrics; 1980 Jan; 65(1):125-31. PubMed ID: 7355006
[TBL] [Abstract][Full Text] [Related]
16. Antithrombin III Avranches, a new variant with defective serine-protease inhibition--comparison with antithrombin III Charleville.
Aiach M; Roncato M; Chadeuf G; Dezellus P; Capron L; Fiessinger JN
Thromb Haemost; 1988 Aug; 60(1):94-6. PubMed ID: 3187951
[TBL] [Abstract][Full Text] [Related]
17. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
Jørgensen M; Petersen LC; Thorsen S
J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440
[TBL] [Abstract][Full Text] [Related]
18. Antithrombin III Nagasaki (Ser116-Pro): a heterozygous variant with defective heparin binding associated with thrombosis.
Okajima K; Abe H; Maeda S; Motomura M; Tsujihata M; Nagataki S; Okabe H; Takatsuki K
Blood; 1993 Mar; 81(5):1300-5. PubMed ID: 8443391
[TBL] [Abstract][Full Text] [Related]
19. [Homozygous (or double heterozygous) antithrombin III defect: AT-III, Budapest 4].
Csurgay E; Petö I; Samu A; Sas G
Orv Hetil; 1991 May; 132(18):967-70. PubMed ID: 2027669
[TBL] [Abstract][Full Text] [Related]
20. Antithrombin III Padua: a "new" congenital antithrombin III abnormality with normal or near normal activity, normal antigen, abnormal migration and no thrombotic disease.
Girolami A; Pengo V; Cappellato G; Vianello C; Procidano M; Cartei C
Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(1):98-111. PubMed ID: 6192061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
